Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation CHENGDU, China, May 22, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.… CISION PRNewswireMay 22, 2025
New chapter in China-LAC cooperation: Though oceans apart, kindred spirits remain connected BEIJING, May 22, 2025 /PRNewswire/ — A news report from China.org.cn on the… CISION PRNewswireMay 22, 2025
Press Release Unleashing Next Generation Storage Power | HIKSEMI Showcases Latest Storage Solutions at COMPUTEX 2025 TAIPEI, May 22, 2025 /PRNewswire/ — HIKSEMI, a global provider of professional data… CISION PRNewswireMay 22, 2025
AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients TAIPEI, May 22, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd., a clinical-stage… CISION PRNewswireMay 22, 2025
Press Release Marketplace Battle Heats Up: Trust, Convenience and Choice Key as Pricing Pressures Grow MELBOURNE , Australia, May 22, 2025 /PRNewswire/ — An exclusive Australian study… CISION PRNewswireMay 22, 2025
Press Release Huntsman Corporation Announces New Purification and Packaging Capability through its E-GRADE® Unit in Conroe, Texas THE WOODLANDS, Texas, May 22, 2025 /PRNewswire/ — Huntsman Corporation (NYSE: HUN),… CISION PRNewswireMay 22, 2025
RD Technologies Celebrates Passage of Stablecoins Ordinance in Hong Kong HONG KONG, May 22, 2025 /PRNewswire/ — RD Technologies, a Hong Kong-based… CISION PRNewswireMay 22, 2025
Press Release Prime Focus Technologies expands Southeast Asia presence with strategic partnerships in Indonesia and the Philippines LOS ANGELES, May 22, 2025 /PRNewswire/ — Prime Focus Technologies (PFT), the… CISION PRNewswireMay 22, 2025
